| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,704 |
21,132 |
$1.23M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,919 |
7,291 |
$552K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,414 |
5,105 |
$380K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,563 |
7,068 |
$267K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,773 |
3,511 |
$248K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
11,370 |
10,589 |
$231K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,168 |
2,038 |
$147K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
10,277 |
9,199 |
$114K |
| 90461 |
|
4,169 |
3,933 |
$85K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,597 |
2,163 |
$49K |
| 92587 |
|
2,347 |
2,224 |
$42K |
| 92551 |
|
3,943 |
3,668 |
$39K |
| 90677 |
|
376 |
287 |
$38K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
993 |
956 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,176 |
2,954 |
$34K |
| 90671 |
|
224 |
190 |
$27K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,461 |
2,321 |
$27K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
337 |
330 |
$24K |
| 90670 |
|
1,039 |
1,029 |
$16K |
| 90651 |
|
109 |
105 |
$14K |
| 90619 |
|
106 |
106 |
$12K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
791 |
766 |
$12K |
| 90686 |
|
1,824 |
1,690 |
$11K |
| 97802 |
|
666 |
660 |
$9K |
| 99188 |
|
403 |
396 |
$7K |
| 96160 |
|
3,158 |
2,861 |
$5K |
| 90698 |
|
826 |
771 |
$5K |
| 99177 |
|
730 |
641 |
$5K |
| 90710 |
|
101 |
88 |
$5K |
| 99381 |
|
94 |
88 |
$4K |
| 90680 |
|
743 |
686 |
$4K |
| 90633 |
|
595 |
564 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
74 |
73 |
$2K |
| 90716 |
|
121 |
117 |
$2K |
| 99174 |
|
837 |
807 |
$2K |
| 85018 |
|
1,217 |
1,095 |
$2K |
| 96161 |
|
745 |
695 |
$2K |
| 83655 |
|
414 |
386 |
$1K |
| 96127 |
|
426 |
402 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$1K |
| 90715 |
|
63 |
62 |
$1K |
| 90707 |
|
172 |
153 |
$1K |
| 90696 |
|
86 |
74 |
$1K |
| 99173 |
|
1,427 |
1,253 |
$905.16 |
| 90744 |
|
414 |
395 |
$799.76 |
| 99051 |
|
847 |
808 |
$740.28 |
| 90656 |
|
102 |
102 |
$501.08 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
29 |
29 |
$473.29 |
| 36415 |
Collection of venous blood by venipuncture |
178 |
173 |
$456.73 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
14 |
$424.19 |
| 90700 |
|
86 |
85 |
$352.05 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
26 |
26 |
$351.49 |
| 90648 |
|
101 |
78 |
$263.03 |
| 94760 |
|
1,409 |
1,217 |
$242.55 |
| 90688 |
|
157 |
137 |
$172.30 |
| 92567 |
|
19 |
18 |
$164.82 |
| 99000 |
|
1,025 |
970 |
$127.60 |
| 90660 |
|
21 |
21 |
$77.07 |
| 90661 |
|
42 |
42 |
$49.68 |
| 99072 |
|
1,090 |
1,043 |
$37.80 |
| 36416 |
|
103 |
99 |
$12.33 |
| 81003 |
|
31 |
29 |
$5.53 |
| 91307 |
|
74 |
68 |
$0.00 |
| 90723 |
|
12 |
12 |
$0.00 |